← Eichor
Study identifier: NCT05347238 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Condition: Late-Onset Neonatal Sepsis · Extreme Prematurity · Neonatal Hypotension  ·  Sponsor: Mount Sinai Hospital, Canada

PhaseN/A
Planned participants550
Who can joinAll sexes, 21 Weeks to 32 Weeks
Healthy volunteersNo

About this study

Fluid-unresponsive hypotension needing cardiotropic drug treatment is a serious complication in very preterm neonates with suspected late-onset sepsis (LOS; defined as culture positive or negative bloodstream infection or necrotizing enterocolitis occurring \>48 hours of age). In Canada, \~250 very preterm neonates receive cardiotropic drugs for LOS related fluid-unresponsive hypotension every year; of these \~35-40% die. Unlike for adult patients, there is little evidence to inform practice. While several medications are used by clinicians, the most frequently used medications are Dopamine (DA) and Norepinephrine (NE). However, their relative impact on patient outcomes and safety is not known resulting in significant uncertainty and inter- and intra-unit variability in practice. Conducting large randomized trials in this subpopulation can be operationally challenging and expensive. Comparative effectiveness research (CER), is a feasible alternative which can generate high-quality real-world evidence using real-world data, by comparing the impact of different clinical practices. Aim: To conduct an international CER study, using a pragmatic clinical trial design, in conjunction with the existing infrastructure of the Canadian Neonatal Network to identify the optimal management of hypotension in very preterm neonates with suspected LOS. Objective: To compare the relative effectiveness and safety of pharmacologically equivalent dosages of DA versus NE for primary pharmacothera…

This description comes directly from the study's public registry record.

Talk to the study team

Amish Jain, MBBS, MRCPCH, PhD  ·  416-586-4800  ·  amish.jain@sinaihealth.ca

Laura Thomas, MSc  ·  416-586-4800  ·  laura.thomas@sinaihealth.ca

Always discuss trial participation with your own doctor first.

Locations (23)

Banner-University Medical Center PhoenixPhoenix, Arizona, United StatesNot Yet Recruiting
Dayton Children's HospitalDayton, Ohio, United StatesRecruiting
Methodist HealthcareSan Antonio, Texas, United StatesRecruiting
Foothill's Medical CentreCalgary, Alberta, CanadaRecruiting
BC Women's HospitalVancouver, British Columbia, CanadaRecruiting
Victoria General HospitalVictoria, British Columbia, CanadaRecruiting
St.Boniface HospitalWinnipeg, Manitoba, CanadaNot Yet Recruiting
Winnipeg Health Sciences CentreWinnipeg, Manitoba, CanadaRecruiting
IWK Health CentreHalifax, Nova Scotia, CanadaRecruiting
McMaster Children's HospitalHamilton, Ontario, CanadaRecruiting
London Health Sciences CentreLondon, Ontario, CanadaRecruiting
Children's Hospital of Eastern OntarioOttawa, Ontario, CanadaRecruiting

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05347238